Provided By GlobeNewswire
Last update: Oct 22, 2025
Company previously announced it was selected as a finalist from more than 1,800 submissions
Award win underscores growing impact of Aclarion’s breakthrough Nociscan solution for chronic low back pain
Read more at globenewswire.comNASDAQ:ACONW (12/2/2025, 12:54:34 PM)
0.0404
-0.01 (-17.04%)
NASDAQ:ACON (12/2/2025, 3:14:27 PM)
7.06
+0.56 (+8.62%)
Find more stocks in the Stock Screener


